Pathfinder Cell Therapy Inc (PFND)
0.00
USD |
OTCM |
Sep 26, 16:00
Pathfinder Cell Therapy Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
September 29, 2010 | 52.74 |
September 28, 2010 | 52.74 |
September 27, 2010 | 65.92 |
September 24, 2010 | 65.92 |
September 23, 2010 | 65.92 |
September 22, 2010 | 65.92 |
September 21, 2010 | 112.07 |
September 20, 2010 | 79.11 |
September 17, 2010 | 52.74 |
September 16, 2010 | 79.11 |
September 15, 2010 | 52.74 |
September 14, 2010 | 52.74 |
September 13, 2010 | 52.74 |
September 10, 2010 | 52.74 |
September 09, 2010 | 52.74 |
September 08, 2010 | 52.74 |
September 07, 2010 | 52.74 |
September 03, 2010 | 92.29 |
September 02, 2010 | 52.74 |
September 01, 2010 | 92.29 |
August 31, 2010 | 92.29 |
August 30, 2010 | 72.51 |
August 27, 2010 | 72.51 |
August 26, 2010 | 98.88 |
August 25, 2010 | 98.88 |
Date | Value |
---|---|
August 24, 2010 | 98.88 |
August 23, 2010 | 98.88 |
August 20, 2010 | 85.70 |
August 19, 2010 | 65.92 |
August 18, 2010 | 85.70 |
August 17, 2010 | 85.70 |
August 16, 2010 | 85.70 |
August 13, 2010 | 85.70 |
August 12, 2010 | 85.70 |
August 11, 2010 | 85.70 |
August 10, 2010 | 92.29 |
August 09, 2010 | 98.88 |
August 06, 2010 | 98.88 |
August 05, 2010 | 98.88 |
August 04, 2010 | 92.29 |
August 03, 2010 | 89.65 |
August 02, 2010 | 89.65 |
July 30, 2010 | 89.65 |
July 29, 2010 | 89.65 |
July 28, 2010 | 92.29 |
July 27, 2010 | 92.29 |
July 26, 2010 | 92.29 |
July 23, 2010 | 79.11 |
July 22, 2010 | 65.92 |
July 21, 2010 | 112.07 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
NovaBay Pharmaceuticals Inc | -- |
Palatin Technologies Inc | 10.31 |
iBio Inc | 0.8405 |
Theriva Biologics Inc | 0.0571 |
Oragenics Inc | -- |